The Path to Innovation
Clayton M. Christensen is a professor of business administration at the Harvard Business School. He is the bestselling author of five books, including his seminal work, The Innovator's Dilemma, which received the Global Business Book Award for the best business book of the year, and most recently, The Innovator's Prescription, which examines how to fix our healthcare system. Christensen serves on several public and privately traded boards and is the founder of a successful consulting company and an investment management firm. He holds a B.A. with highest honors in economics from Brigham Young University and an M.Phil. in applied econometrics and the economics of less-developed countries from Oxford University, where he studied as a Rhodes Scholar; he received an MBA with high distinction from the Harvard Business School in 1979, graduating as a George F. Baker Scholar, and was awarded his DBA from the Harvard Business School in 1992.
Question: Why is innovation so difficult?
Christensen: It’s hard to foster an innovative culture because the activities of executing the business that you already have and manufacturing with very high levels of quality, satisfying customers’ needs are [entailed] being very deliberate and repetitive in order to be successful. Innovation is not quite as predictable, especially if you’re developing an innovation that would appeal to a different set of customers than the ones that you’re currently serving. And, as a consequence, innovations that help you do a better job serving your existing customers are rarely a problem. It’s innovations that target a new set of customers with something that is simpler and more convenient, those are the ones that you have trouble with because it just makes no sense to the logic of the organization to spend money developing products that your customers can’t use.
Question: How can companies identify opportunities for innovation?
Christensen: What you have to do is just, as you’re walking around the world, keep your eyes out for where are they doing something in a location that is inconvenient and expensive and difficult where I could bring a technology to it that would enable it to be done in a much simpler location with greater convenience at lower cost, or where they’re doing something in a centralized location where I could decentralize it, where is there a population of people who cannot now afford something where my technology would enable it to be, enable them to afford it. A great opportunity, actually, is in… A good illustration of this is in green energy. There are no non-consumers of energy in the United States and Europe. Basically everybody has access to very reliable, cost-effective power over the electrical grid or gasoline through the petroleum industry, and what that means is disruptive innovations are unlikely ever to take root here. Ultimately, they may penetrate this market, but they won’t take root here. Where they take root is amongst the 2 billion people in Asia and Africa who don’t yet have electricity, and they’re the ones who would be, who really need to be given a product that is simple, affordable, convenient, where everybody could generate the electricity at their homes rather than have to go through their cost of building the electrical grid. And then, in that context, the technology gets better and better until ultimately it can be used in North America and Europe. But that’s just an illustration. You’ve got to look for a population that can afford it, doesn’t have access to it, simplify the technology so that they can, and that’s the disruption that we’re talking about.
The Harvard Business School professor on how to break down barriers to innovation.
It marks a major shift in the government's battle against the opioid crisis.
- The nation's sixth-largest drug distributor is facing criminal charges related to failing to report suspicious drug orders, among other things.
- It marks the first time a drug company has faced criminal charges for distributing opioids.
- Since 1997, nearly 222,000 Americans have died from prescription opioids, partly thanks to unethical doctors who abuse the system.
Upstreamism advocate Rishi Manchanda calls us to understand health not as a "personal responsibility" but a "common good."
- Upstreamism tasks health care professionals to combat unhealthy social and cultural influences that exist outside — or upstream — of medical facilities.
- Patients from low-income neighborhoods are most at risk of negative health impacts.
- Thankfully, health care professionals are not alone. Upstreamism is increasingly part of our cultural consciousness.
The real Game of Thrones might be who best leverages the hit HBO show to shape political narratives.
- Sen. Elizabeth Warren argues that Game of Thrones is primarily about women in her review of the wildly popular HBO show.
- Warren also touches on other parallels between the show and our modern world, such as inequality, political favoritism of the elite, and the dire impact of different leadership styles on the lives of the people.
- Her review serves as another example of using Game of Thrones as a political analogy and a tool for framing political narratives.
SMARTER FASTER trademarks owned by The Big Think, Inc. All rights reserved.